TheStreet

Log In

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?Don't have an account? Sign Up Here

Join Us

Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Already have an account? Login here
TheStreet
JIM CRAMERINVESTINGPERSONAL FINANCERETIREMENTTECHNOLOGYMARKETSHOW-TOVIDEOFINANCIAL ADVISOR CENTER
Search

Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

SUBSCRIBE NOW

LATEST NEWS

Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor
Play
INVESTING

Adamis Soars After Submitting Covid Drug to FDA

  • By Dan Weil
  • Jan 20, 2021 1:06 PM EST
Adamis Pharma Shares Soar on Deal With Novartis for Epipen Competitor
INVESTING

Adamis Soars After Submitting Covid Drug to FDA

  • By Dan Weil
  • Jan 20, 2021 1:06 PM EST
PRESS RELEASES

Adamis Pharmaceuticals Announces IND Submission To FDA For Tempol For The Treatment Of COVID-19

  • By GlobeNewswire
  • Jan 20, 2021 9:00 AM EST
PRESS RELEASES

Adamis Pharmaceuticals Describes Planned Response To ZIMHI Complete Response Letter

  • By GlobeNewswire
  • Dec 1, 2020 9:00 AM EST
PRESS RELEASES

Adamis Pharmaceuticals Receives A Complete Response Letter From The FDA Regarding ZIMHI

  • By GlobeNewswire
  • Nov 16, 2020 6:45 AM EST
PRESS RELEASES

Adamis Pharmaceuticals Announces Third Quarter 2020 Financial Results And Business Update

  • By GlobeNewswire
  • Nov 9, 2020 4:30 PM EST
PRESS RELEASES

Adamis Pharmaceuticals Announces Pricing Of Public Offering Of Common Stock

  • By GlobeNewswire
  • Sep 18, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Proposed Public Offering Of Common Stock

  • By GlobeNewswire
  • Sep 17, 2020 4:05 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders

  • By GlobeNewswire
  • Sep 3, 2020 4:05 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders And Proposals

  • By GlobeNewswire
  • Aug 25, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Provides Update On Annual Meeting Of Stockholders

  • By GlobeNewswire
  • Aug 21, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Second Quarter 2020 Financial Results And Business Update

  • By GlobeNewswire
  • Aug 17, 2020 4:40 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Pre-IND Feedback From FDA Enabling Advancement Of Tempol, A Novel Anti-Inflammatory And Anti-Oxidant Drug For The Treatment Of COVID-19

  • By GlobeNewswire
  • Aug 14, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Regains Compliance With NASDAQ Minimum Bid Price Requirement

  • By GlobeNewswire
  • Aug 5, 2020 4:05 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Provides Update On SYMJEPI Products

  • By GlobeNewswire
  • Jul 1, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Publication Of Pharmacokinetic Model Suggesting That Higher Doses Of Naloxone Are Needed For Successful Resuscitation Due To Fentanyl Overdose

  • By GlobeNewswire
  • Jun 18, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces License To Commercialize Tempol, A Novel Investigational Anti-inflammatory And Antioxidant Drug For The Treatment Of Respiratory Diseases Including COVID-19

  • By GlobeNewswire
  • Jun 15, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces First Quarter 2020 Financial Results And Business Update

  • By GlobeNewswire
  • May 18, 2020 4:35 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application To FDA

  • By GlobeNewswire
  • May 18, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Schedules First Quarter 2020 Earnings Conference Call And Business Update

  • By GlobeNewswire
  • May 15, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Provides Update On SYMJEPI Products And Announces Distribution And Commercialization Agreement For SYMJEPI And ZIMHI Products

  • By GlobeNewswire
  • May 11, 2020 8:35 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Publication Demonstrating PET Scan Results Of Higher Dose Naloxone In Monkeys

  • By GlobeNewswire
  • Apr 23, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Production Of Additional Drugs By Its US Compounding Subsidiary To Aid In The COVID-19 Pandemic

  • By GlobeNewswire
  • Apr 21, 2020 9:00 AM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Receipt Of Loan Proceeds Under Paycheck Protection Program

  • By GlobeNewswire
  • Apr 15, 2020 4:05 PM EDT
PRESS RELEASES

Adamis Pharmaceuticals Announces Production Of Products By Its Subsidiary US Compounding To Aid In The COVID-19 Pandemic

  • By GlobeNewswire
  • Apr 1, 2020 9:00 AM EDT
TheStreet
  • Terms Of Use
  • Privacy Policy
  • Advertise
  • Reprints
  • Customer Service
  • Data
  • Topic Archive
  • Subscriptions
© 2021 TheStreet, Inc. All rights reserved. Action Alerts PLUS is a registered trademark of TheStreet, Inc.